Moreover, the accompanying involution process is fueled by Stat3-driven CLP overexpression [46], providing a targetable environment for chitin treatment and allowing to investigate therapeutic efficacy in the context of pregnancy-associated BC, a rarely studied but aggressive BC with often TNBC characteristics [47]. The gene discussed is STAT3; the disease is breast cancer.